.STUDY EMPHASIZE.16 October 2024. In the NIAGARA litigation, the addition of perioperative durvalumab to basic therapy for muscle-invasive bladder cancer cells enhanced event-free as well as in general survival, marking a brand new procedure alternative for this health condition.